Savior Lifetec Corp 4167
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 21.35
- Day Range
- TWD 21.25–21.80
- 52-Week Range
- TWD 16.75–27.00
- Bid/Ask
- TWD 21.30 / TWD 21.35
- Market Cap
- TWD 6.76 Bil
- Volume/Avg
- 1.4 Mil / 2.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 1,126.59
- Price/Sales
- 6.78
- Dividend Yield (Trailing)
- 0.48%
- Dividend Yield (Forward)
- 0.48%
- Total Yield
- 0.48%
Company Profile
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 378
- Website
- https://www.saviorlifetec.com.tw
Comparables
Valuation
|
Metric
|
4167
|
6676
|
1734
|
|---|---|---|---|
Price/Earnings (Normalized) | 1,126.59 | — | 16.78 |
Price/Book Value | 2.02 | 3.52 | 2.01 |
Price/Sales | 6.78 | 9.53 | 2.11 |
Price/Cash Flow | 41.17 | 57.28 | 14.60 |
Price/Earnings
4167
6676
1734
Financial Strength
|
Metric
|
4167
|
6676
|
1734
|
|---|---|---|---|
Quick Ratio | 8.09 | 2.99 | 1.43 |
Current Ratio | 12.67 | 4.12 | 2.20 |
Interest Coverage | −0.69 | −5.14 | 9.70 |
Quick Ratio
4167
6676
1734
Profitability
|
Metric
|
4167
|
6676
|
1734
|
|---|---|---|---|
Return on Assets (Normalized) | 0.09% | −2.97% | 5.80% |
Return on Equity (Normalized) | 0.11% | −4.78% | 11.80% |
Return on Invested Capital (Normalized) | −0.80% | −2.83% | 7.23% |
Return on Assets
4167
6676
1734
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Cqngkhkzff | Wts | $567.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ncldsnkvw | Npsthx | $106.9 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cctlkzs | Mtcbgw | $105.9 Bil | |
MRNA
| Moderna Inc | Gkyscsnct | Cbdk | $46.4 Bil | |
ARGX
| argenx SE ADR | Jyjvsdbjs | Rjz | $23.5 Bil | |
BNTX
| BioNTech SE ADR | Hqjmxqgl | Dzhyv | $21.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Clwjtylkg | Xnrmht | $19.5 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bqhqkxwcj | Drgzmg | $15.7 Bil | |
RPRX
| Royalty Pharma PLC Class A | Hnfbhkfsnz | Gkdpws | $12.8 Bil | |
INCY
| Incyte Corp | Rrzwkrmn | Yjhgq | $12.2 Bil |